{"nct_id":"NCT03800134","title":"A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2018-12-06","start_date_type":"ACTUAL","primary_completion_date":"2022-11-10","primary_completion_date_type":"ACTUAL","completion_date":"2028-09-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}